Clinical trials sponsored by The Netherlands Cancer Institute

Phase breakdown

Conditions studied

Recruiting trials led by The Netherlands Cancer Institute

• Basket Study for Oligo-metastatic Breast Cancer
  NCT05982678 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Contrast-enhanced Ultrasound for Sentinel Node Detection
  NCT07310758 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy
  NCT05416164 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two Fractions
  NCT07391982 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Earlier Detection and Optimization of Treatment and Prognosis for Patients With Early-onset Colorectal Cancer
  NCT06568679 · Phase: Not specified · Ages: 18 Years to 49 Years · Sex: All (male and female) · 1 location
• FMT to Convert Response to Immunotherapy
  NCT05251389 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)
  NCT06691776 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMER
  NCT06528743 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma
  NCT06240143 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients
  NCT06012734 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study
  NCT06162559 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases
  NCT07511933 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local Excision
  NCT05772923 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II)
  NCT06875258 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: Male · 3 locations
• The Prognostic Role of Lymph Node Dissection In Men With Prostate Cancer Treated With Radical Prostatectomy
  NCT05109910 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials is The Netherlands Cancer Institute recruiting for?

The Netherlands Cancer Institute is the lead sponsor of 15 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.